The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Miyuki Azuma sits on this spectrum.
This scientist: 333 publications — 70th percentile
70% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 807 publications or more.
The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Miyuki Azuma sits on this spectrum.
This scientist: 92 D-Index — 80th percentile
80% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 157 D-Index or more.
Miyuki Azuma is affiliated with Tokyo Medical and Dental University in Japan. Their research primarily focuses on immunology and microbiology, with significant contributions to medicine. The subfields of study include immunology, oncology, genetics, pulmonary and respiratory medicine, and surgery.
The scientist's work extensively covers topics related to cancer immunotherapy and biomarkers, immunotherapy and immune responses, and immune cell function and interaction. Other prominent topics in their research include immune cells in cancer, CAR-T cell therapy research, immune response and inflammation, and T-cell and B-cell immunology.
Miyuki Azuma has collaborated frequently with colleagues including Shigenori Nagai, Naoto Nishii, Yohei Kawano, Pissacha Daroonpan, and Hiroyuki Harada.
Their recent published papers include:
- Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade, 2022, Diabetologia
- PD-L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment, 2021, Communications Biology
- High density and proximity of CD8+T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma, 2023, Thoracic Cancer
- Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model, 2020, Cancer Immunology Immunotherapy
- Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclusters, 2023, Nature Communications
Publication venues where Miyuki Azuma's work appears regularly include:
Tomohide Yamazaki;Hisaya Akiba;Hideyuki Iwai;Hironori Matsuda
Takeo Nomi;Masayuki Sho;Takahiro Akahori;Kaoru Hamada
Tadashi Yokosuka;Masako Takamatsu;Wakana Kobayashi-Imanishi;Akiko Hashimoto-Tane
Miyuki Azuma;Daisuke Ito;Daisuke Ito;Hideo Yagita;Ko Okumura
Yuichiro Ohigashi;Masayuki Sho;Yukishige Yamada;Yoshikazu Tsurui
Mohammed Javeed I. Ansari;Alan D. Salama;Alan D. Salama;Tanuja Chitnis;Tanuja Chitnis;R. Neal Smith
Jun Konishi;Koichi Yamazaki;Miyuki Azuma;Ichiro Kinoshita
Madhav D. Sharma;Babak Baban;Phillip Chandler;De Yan Hou
Brian T Fife;Kristen E Pauken;Todd N Eagar;Takashi Obu
K Inaba;M Witmer-Pack;M Inaba;K S Hathcock
Qing Zhou;Meghan E. Munger;Rachelle G. Veenstra;Brenda J. Weigel
M G Cifone;R De Maria;P Roncaioli;M R Rippo
L L Lanier;S O'Fallon;C Somoza;J H Phillips
Alan D. Salama;Tanuja Chitnis;Tanuja Chitnis;Jaime Imitola;Jaime Imitola;Mohammed Javeed I. Ansari
Juro Nakanishi;Yoshihiro Wada;Koichiro Matsumoto;Miyuki Azuma
Masafumi Nakayama;Hisaya Akiba;Kazuyoshi Takeda;Yuko Kojima
M Azuma;J H Phillips;L L Lanier
Indira Guleria;Arezou Khosroshahi;Mohammed Javeed I Ansari;Antje Habicht
Miyuki Azuma;Mark Cayabyab;David Buck;Joseph H. Phillips
C Caux;B Vanbervliet;C Massacrier;M Azuma
If you think any of the details on this page are incorrect, let us know.
For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students transition from nursing to specialized roles, making programs like accelerated RN to NP programs an excellent option for advancing clinical expertise and leadership skills. These programs are designed to fast-track nurses into nurse practitioner roles, often with flexible online options.
Beginners without prior nursing experience might consider online BSN programs for non nurses. Such programs enable students to enter the nursing field with a strong academic foundation, often featuring online coursework that fits varying schedules, supporting working professionals or career changers.
For a quicker entry into nursing, the easiest accelerated nursing programs provide accessible pathways that prioritize foundational nursing knowledge and minimize admission hurdles. These programs suit individuals eager to start their healthcare careers without lengthy prerequisites.
Additionally, those aiming for practical nursing roles might explore LPN programs with easiest admission requirements. Licensed Practical Nurse programs offer essential training and certification with obtainable entry standards, acting as a stepping stone within the healthcare system.
National Institutes of Health
Texas A&M University
National Tsing Hua University
National Yang Ming Chiao Tung University
Stanford University
University of Münster
University of Queensland
Statens Serum Institut
Centre national de la recherche scientifique, CNRS
Lanzhou University
University of Wyoming
University of Murcia
Stanford University
University of New South Wales
University of British Columbia
Hokkaido University
